Q3 2024 · 13F-HR
Paradigm Biocapital Advisors LPholdings as filed
Filed 2024-11-14 · accession 0001855655-24-000014
$2.96B
Reported value
33
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 670703107 | NUVL | NUVALENT INC | $511.5M | 17.3% | 5,000,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $334.0M | 11.3% | 4,000,000 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $260.4M | 8.81% | 480,374 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $241.0M | 8.15% | 5,314,089 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $128.6M | 4.35% | 2,516,686 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $122.6M | 4.15% | 2,454,917 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $109.1M | 3.69% | 2,400,574 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $84.6M | 2.86% | 4,331,321 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $80.3M | 2.72% | 2,440,445 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $74.4M | 2.52% | 2,789,172 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $73.6M | 2.49% | 1,497,720 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $71.7M | 2.43% | 627,732 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $66.8M | 2.26% | 800,000 | CALL | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $65.9M | 2.23% | 2,895,689 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $65.7M | 2.22% | 5,503,600 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $57.6M | 1.95% | 2,339,961 | Common | SOLE |
| 984241109 | YMABUSD | Y-MABS THERAPEUTICS INC | $53.7M | 1.82% | 4,086,346 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $49.8M | 1.68% | 4,609,762 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $48.5M | 1.64% | 1,096,851 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $47.0M | 1.59% | 931,480 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $45.0M | 1.52% | 200,336 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $44.6M | 1.51% | 3,904,862 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $41.2M | 1.39% | 701,817 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $38.9M | 1.31% | 1,362,827 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $38.9M | 1.31% | 2,321,013 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $37.3M | 1.26% | 1,267,581 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $34.8M | 1.18% | 3,104,486 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $31.6M | 1.07% | 276,800 | CALL | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $30.5M | 1.03% | 525,037 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $29.1M | 0.99% | 10,668,141 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $17.6M | 0.60% | 719,660 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $12.3M | 0.42% | 919,692 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $7.3M | 0.25% | 1,160,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.